Position in LLY
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$5,051,998
+$1,106,186 QoQ
Shares Held
4,212
-1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.55%
of 13F equity value
Holder Rank
#1,706
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST FINANCIAL CORP /IN/ holds $10,663,305 across 12 Drug Manufacturers - General names. LLY ranks #1 (47.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
4,212 | $5,051,998 | |
| 2 | ABBV |
AbbVie Inc.
|
9,288 | $2,337,231 | |
| 3 | MRK |
Merck & Co., Inc.
|
11,730 | $1,507,305 | |
| 4 | JNJ |
Johnson & Johnson
|
2,095 | $532,067 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,635 | $497,548 | |
| 6 | NVO |
Novo Nordisk A S
|
6,470 | $310,171 | |
| 7 | PFE |
Pfizer Inc
|
10,210 | $245,856 | |
| 8 | NVS |
Novartis AG
|
599 | $93,875 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,051,998 | 4,212 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $3,945,812 | 4,290 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $4,862,927 | 4,525 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $3,534,216 | 4,632 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $3,718,357 | 4,770 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $3,753,760 | 4,545 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $3,477,088 | 4,504 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $4,303,010 | 4,857 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $4,898,104 | 5,410 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $3,429,247 | 4,408 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $2,761,291 | 4,737 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $2,567,481 | 4,780 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $2,269,393 | 4,839 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,028,924 | 5,908 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $2,397,715 | 6,554 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $2,185,198 | 6,758 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,180,122 | 6,724 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,935,574 | 6,759 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $1,832,442 | 6,634 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $1,595,862 | 6,907 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $1,643,362 | 7,160 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,386,764 | 7,423 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $1,325,562 | 7,851 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $1,096,679 | 7,409 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,276,991 | 7,778 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $1,312,984 | 9,465 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||